« Royal Society shortlist suggestions for holiday reading | Main | A second take on 'ghost' authorship »

Bookmark in Connotea

Development of RNAi as a therapeutic strategy

Molecular Therapy presents a special web focus, gathering together top articles on RNAi originally published in Molecular Therapy, Nature, Nature Medicine, Nature Reviews Genetics, Nature Reviews Drug Discovery, British Journal of Cancer and other NPG journals, free to access for a limited time. This collection covers latest research on the development of RNAi-based tools for drug target and gene function analysis as well as work describing the development of the technology for therapeutic applications.

Posted by Maxine Clarke on May 20, 2008
Categories: Author benefits | | Comments (0)

Post a comment

Comments will be reviewed by the blog editors before being published, mainly to ensure that spam and irrelevant material (such as product advertisements) are not published . Please keep your comment brief. Excessively long or offensively phrased entries will be edited. Remember this blog is for feedback and discussion of matters concerning scientific authorship or peer-review - not for drawing attention to your research.

If you want to know if a NPG journal would be interested in your research, you will need to contact the journal's editorial office, which can be done via the authors & referees website.

We strongly encourage you to use your real, full name. E-mail addresses are required in case we need to discuss your comment with you directly. We won't publish your e-mail address unless you request it.

Please enter the numbers you see below - this helps us to avoid spam. If you are having trouble with this system, you can send your comment by e-mail to 'authors at nature dot com'.

please enter code

Search